SCLERO.ORG is retiring 4-24-2021. Thank you for the memories! You'll still find us in the Wayback Machine, and we'll carry your stories in our hearts forever.
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Media Stories
Autoimmune Archive
We maintain news archives for the most recent 3 years.
2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 - 2020 - 2019 - 2018

January 2020 Autoimmune News

Case Report: Eosinophilic Fasciitis Responds Well to Steroids and Methotrexate. There was an excellent response to steroids and methotrexate, which is not a combination therapy that has been tried or mentioned previously. PubMed, Oman Med J, 2019 Nov;34(6):564-567. (Also see Eosinophilic Fasciitis)

The Trick of Treating Cancer in Autoimmune Diseases. For patients without a normal immune system immunotherapy could supercharge existing problems in the immune system, causing severe adverse effects that could worsen symptoms. Medscape,12/06/2019. (Also see Cancer)

Outcome Measures in Large-Vessel Vasculitis: Relationship Between Patient, Physician, Imaging, and Laboratory-Based Assessments. Measures of disease assessment in large-vessel vasculitis consist of independent outcomes, supporting the need to develop a standard set of measures covering multiple types of outcomes. PubMed, Arthritis Care Res (Hoboken), 11/30/2019. (Also see Vasculitis)

Association between pain phenotype and disease activity in rheumatoid arthritis patients: a non-interventional, longitudinal cohort study. This longitudinal study showed consistently worse long-term disease activity outcomes in RA patients. PubMed, Arthritis Res Ther, 2019 Nov 29;21(1):257. (Also see Symptoms and Complications of Rheumatoid Arthritis)

Risk of congenital anomalies in infants born to women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study. These population-based data suggest that the use of biologics before and during pregnancy is not associated with an increased risk of congenital anomalies. PubMed, Clin Exp Rheumatol, 2019 Nov-Dec;37(6):976-982. (Also see Biologic Agents)

Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction. As yet unrecognized factors may play a role in the development of a xanthomatous reaction in discoid lupus erythematosus. PubMed, Lupus, 2019 Dec 1:961203319890677. (Also see Treatments for Lupus)

Systemic lupus erythematosus (SLE) is a risk factor for atrial fibrillation (AF): a nationwide, population-based study. Development of AF in patients with SLE was associated with increased mortality. PubMed, Clin Exp Rheumatol, 2019 Nov-Dec;37(6):1019-1025. (Also see Symptoms and Complications of Lupus)

Effect of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) on sudden sensorineural hearing loss (SSNHL). Comorbid SLE or RA may negatively affect the prognosis of SSNHL. PubMed, Laryngoscope, 12/04/2019. (Also see Symptoms and Complications of Lupus,Symptoms and Complications of Rheumatoid Arthritis and Autoimmune Ear Diseases)

Novel biomarkers containing citrullinated peptides for diagnosis of systemic lupus erythematosus (SLE) using protein microarrays. A citrullinated/non-citrullinated peptide panel is a valuable diagnostic marker of SLE, even for patients who are negative for anti-Smith, anti-double-stranded DNA, and anticardiolipin. PubMed, Clin Exp Rheumatol, 2019 Nov-Dec;37(6):929-936. (Also see Diagnosis of Lupus)

The Impact of Systemic Lupus Erythematosus (SLE) on the Risk of Newly Diagnosed Hip Fracture. A General Population-Based Study. Patients with newly diagnosed SLE have a 62% increased risk of hip fractures compared to non-SLE individuals. PubMed, Arthritis Care Res (Hoboken), 11/23/2019. (Also see Symptoms and Complications of Lupus)

Go to Autoimmune News: December 2019

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected]. Disclaimer. Privacy Policy.